テキサスにおける1型糖尿病の臨床試験
テキサス内の拠点で、1型糖尿病に関する16件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Driscoll Children's Hospital, Corpus Christi
被験者募集中第3相
1歳〜35歳 · 全性別 · 2026/09/22更新 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Baylor College of Medicine- Site Number : 8400057, Houston
被験者募集中第3相
1歳〜25歳 · 全性別 · 2026/09/14更新 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Texas Diabetes & Endocrinology, Austin
- M3 Wake Research - Dallas, Dallas
- Accurate Clinical Research, Inc, Humble
- 他2件
被験者募集中第1/2相
12歳〜35歳 · 全性別 · 2026/09/11更新 · NCT06783309A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Baylor College of Medicine, Houston
被験者募集中第1/2相
9歳〜20歳 · 全性別 · 2026/09/02更新 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Baylor Scott and White Research Institute, Dallas
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/01更新 · NCT04786262Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring
- Texas A&M University, College Station
被験者募集中健康なボランティア歓迎
18歳〜90歳 · 全性別 · 2026/08/28更新 · NCT07254364Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Texas Diabetes & Endocrinology, Austin
被験者募集中
18歳〜80歳 · 全性別 · 2026/08/28更新 · NCT07599982SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Children's Medical Centre Dallas, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital - Clinical Care Center - Pediatric Renal Clinic, Houston
- 他1件
被験者募集中第2相
5歳〜40歳 · 全性別 · 2026/08/24更新 · NCT07187531INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Baylor College of Medicine, Houston
被験者募集中第2相
6歳〜17歳 · 全性別 · 2026/08/13更新 · NCT07224321Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Baylor College of Medicine, Houston
被験者募集中
14歳〜75歳 · 全性別 · 2026/08/03更新 · NCT07579702Kidney Precision Medicine Project
- University of Texas at Southwestern, Dallas
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/14更新 · NCT04334707Registry for Stage 2 Type 1 Diabetes
- Texas Diabetes & Endocrinology - Austin - North Mopac Expressway- Site Number : 8400040, Austin
- University of Texas - Southwestern Medical Center- Site Number : 8400003, Dallas
- Cook Children's- Site Number : 8400038, Fort Worth
- 他1件
被験者募集中観察研究
全年齢 · 全性別 · 2026/04/13更新 · NCT06481904Immune Function and the Progression to T1D
- Baylor College of Medicine, Center for Research Advancement - Texas Children's Hospital, Houston
被験者募集中観察研究健康なボランティア歓迎
0歳〜100歳 · 全性別 · 2026/04/09更新 · NCT05899439Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Texas Southwestern, Dallas
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06217302TrialNet Pathway to Prevention of T1D
- University of Texas Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
被験者募集中観察研究健康なボランティア歓迎
2歳〜45歳 · 全性別 · 2025/07/01更新 · NCT00097292Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
- WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus Christi
- Woundcentrics Wound Care Center At Corpus Christi South, Corpus Christi
被験者募集中第2相
18歳〜80歳 · 全性別 · 2025/06/12更新 · NCT06810726ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。